BOPI 04 BR/2023 REPERTOIRE NUMERIQUE 22 (54) Antimicrobial african plant based drug and its manufacturing process. (72) PEYOU NDI Marlyse (CM) (73) PEYOU NDI Marlyse, B.P. 8661, YAOUNDE (CM) (57) The plant based antimicrobial drug is an antiinfection formula obtained from multi sequential extraction of medicinal plants using biological fluids: latex, sap and tree wine, instead of usual solvents, most being unsafe for human consumption. It is basically made from the naturally modified bark and sap of Alstonia boonei, Enantia Chloranta, bark and sap of Guibourtia tessmannii and the whole plant of Euphorbia hirta. Resulting in a formula that assembles in efficient and safe proportions natural chemical components including alkaloids, tannins, iridoids, terpenoids, sesquiterpenes, coumarins, phenolic compounds, flavonoids, saponins, resins, sterols, steroids, acidic compounds, glycosides and anthraquinone; in order to allow a holistic efficient destruction of deadly viruses & bacteria at any stage of multiplication and simultaneously that of African frequent co-morbidities, namely malaria, typhoid, fungal infections, cardiovascular diseases, pain and insomnia. Thus, the formula exhibits strong antiviral properties and efficiently prevents the implantation of viruses, along with its replication. The formula anti-inflammatory properties block the cytokine storm development and restore the body's balance. The natural immunomodulatory compounds strengthen the body's capacity to fight infection. The formula provides pre and post-exposure prophylaxis and treatment of viral infectious diseases. /- Consulter le mémoire ________________________________________ (11) 20897 (51) G06Q 10/08 (2018.01); G06Q 30/02 (2018.01); G06Q 50/02 (2018.01); G06Q 50/18 (2018.01) (21) 1202200031 - PCT/US2020/022359 (22) 12/03/2020 (30) US n° 16/812,576 du 09/03/2020 (54) System and process for determining a metric and predictive analysis for compliance of cannabis related products. (72) LOS, Timothy (US) et JOHNSON, Jacob (US) (73) RANTE CORPORATION, 520 Broadway, #200, SANTA MONICA, CA 90401 (US) (74) SPOOR & FISHER Inc. NGWAFOR & PARTNERS SARL, The House of Gideon, Golf/Bastos Quarter, Opposite The American Embassy, Entrance-Saint John Paul II Boulevard, B.P. 8211, YAOUNDE (CM). (57) A cannabis compliance system allows for users and entities to track valid cannabis business activities, whether recreational or medical for compliance. Users and entities are able to validate licenses, activities, beneficial owners, and violations either within the cannabis industry and/or specific cannabis businesses and provide predictive analysis of cannabis data to make business decisions, to comply with legal and regulatory requirements, and establish compliance thresholds through public and private sources, including user-based inputs into the cannabis system from connected devices. The cannabis system may compute a compliance metric for cannabis businesses, which based upon cannabis data may derive multiple and weighted indicia. Users and entities can configure their own metric to meet their needs of compliance worthiness, including weighted indicia for business and compliance purposes. Consulter le mémoire ________________________________________ (11) 20898 (51) G06Q 10/08 (2018.01);
RkJQdWJsaXNoZXIy MTM1NDc3MA==